Who owns the OPTIDART trademark?

The OPTIDART trademark is owned by Genexine, Inc..

What class is the OPTIDART trademark registered in?

The OPTIDART trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OPTIDART?

The USPTO serial number for OPTIDART is 79264896.

What is the registration number for OPTIDART?

OPTIDART is registered under USPTO registration number 6599482.

Sealvo

Home Search: OPTIDARTOPTIDART #79264896

Back

Updated Sep 30, 2026·9 searches this week

View on USPTO TSDR Find similar marks

OPT

USPTO Trademark Record

REGISTERED

OPTIDART

SN 79264896·Reg 6599482·Filed May 17, 2019

Owner Genexine, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OPTIDART (Serial No. 79264896), Registration No. 6599482, is a registered US trademark filed on May 17, 2019 by Genexine, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: December 28, 2027

Conflict Analysis

Full conflict analysis for OPTIDART (SN 79264896) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

OPTIDART (Reg. #6599482) is a registered US trademark that has been protecting its owner, Genexine, Inc., since 2019. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 6 opposition proceedings during prosecution.

FILED

May 17, 2019

SERIAL

79264896

REG#

6599482

REGISTERED

Dec 28, 2021

Filing Information

StatusREGISTERED

Filing DateMay 17, 2019

Serial Number79264896

Registration No.6599482

Registration DateDec 28, 2021

Status DateDec 28, 2021

Published for OppositionOct 12, 2021

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

45 events

NEW REPRESENTATIVE AT IB RECEIVED

Feb 07, 2025

NEW REPRESENTATIVE AT IB RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Nov 28, 2024

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Jul 05, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Jun 10, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Jun 09, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Mar 28, 2022

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Dec 28, 2021

REGISTERED-PRINCIPAL REGISTER

NOTIFICATION PROCESSED BY IB

Oct 24, 2021

NOTIFICATION PROCESSED BY IB

PUBLISHED FOR OPPOSITION

Oct 12, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 12, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 22, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Sep 22, 2021

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 22, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 06, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 26, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 26, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 26, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Jul 14, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 14, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 14, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 26, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 26, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

May 25, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

May 19, 2021

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jan 30, 2021

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Jan 13, 2021

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jan 13, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

ASSIGNED TO LIE

Nov 12, 2020

ASSIGNED TO LIE

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Nov 12, 2020

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

NEW REPRESENTATIVE AT IB RECEIVED

May 28, 2020

NEW REPRESENTATIVE AT IB RECEIVED

SUSPENSION LETTER WRITTEN

Apr 01, 2020

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Apr 01, 2020

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Apr 01, 2020

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 07, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 07, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 07, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Sep 28, 2019

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Sep 11, 2019

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 11, 2019

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 27, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Aug 26, 2019

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

Aug 24, 2019

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 20, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Aug 20, 2019

ASSIGNED TO EXAMINER

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 08, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Genexine, Inc.

Additional USPTO filings from the same owner.

HYF

HYFC TECHNOLOGY

98766268

Genexine, Inc.

REGISTERED

GEN

GENEXINE

79164375

Genexine, Inc.

REGISTERED

EFE

EFESA

79391354

Genexine, Inc.

REGISTERED

FID

FIDVAXI

79352877

Genexine, Inc.

REGISTERED

Other Marks by James R Menker

Additional USPTO filings handled by the same attorney of record.

LEA

LEARJET 40

97182366

REGISTERED

BRA

BRAVO HEALTH

99285016

REGISTERED

SWI

SWISS RE

74566677

REGISTERED

CXC

CX CRANIAL EXPANSION

78675092

REGISTERED

OPTIDART

Run a conflict check

Other Marks by Genexine, Inc.

Other Marks by James R Menker

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company